ONCOMED PHARMACEUTICALS INC's ticker is OMED and the CUSIP is 68234X102. A total of 59 filers reported holding ONCOMED PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $33,000 | +37.5% | 31,909 | 0.0% | 0.00% | – |
| Q4 2018 | $24,000 | -64.7% | 31,909 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $68,000 | -8.1% | 31,909 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $74,000 | -26.7% | 31,909 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $101,000 | -39.5% | 31,909 | -21.8% | 0.00% | -25.0% |
| Q4 2017 | $167,000 | +15.2% | 40,795 | +27.3% | 0.00% | 0.0% |
| Q3 2017 | $145,000 | +90.8% | 32,049 | +40.0% | 0.00% | +100.0% |
| Q2 2017 | $76,000 | -49.3% | 22,900 | +54.7% | 0.00% | -50.0% |
| Q1 2016 | $150,000 | – | 14,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|